PH12020551677A1 - Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof - Google Patents

Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Info

Publication number
PH12020551677A1
PH12020551677A1 PH12020551677A PH12020551677A PH12020551677A1 PH 12020551677 A1 PH12020551677 A1 PH 12020551677A1 PH 12020551677 A PH12020551677 A PH 12020551677A PH 12020551677 A PH12020551677 A PH 12020551677A PH 12020551677 A1 PH12020551677 A1 PH 12020551677A1
Authority
PH
Philippines
Prior art keywords
compounds
hyperpigmentation
compositions
chemical analogs
derived compounds
Prior art date
Application number
PH12020551677A
Other languages
English (en)
Inventor
Michael Einziger
Ann Marie Simpson
Original Assignee
Michael Einziger
Ann Marie Simpson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Einziger, Ann Marie Simpson filed Critical Michael Einziger
Publication of PH12020551677A1 publication Critical patent/PH12020551677A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH12020551677A 2018-04-12 2020-10-09 Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof PH12020551677A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862656769P 2018-04-12 2018-04-12
US201862668007P 2018-05-07 2018-05-07
US201862685800P 2018-06-15 2018-06-15
US201862686912P 2018-06-19 2018-06-19
US201862722412P 2018-08-24 2018-08-24
US201862742657P 2018-10-08 2018-10-08
PCT/US2019/027181 WO2019200232A1 (en) 2018-04-12 2019-04-12 Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Publications (1)

Publication Number Publication Date
PH12020551677A1 true PH12020551677A1 (en) 2021-06-28

Family

ID=66380162

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12020551677A PH12020551677A1 (en) 2018-04-12 2020-10-09 Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Country Status (20)

Country Link
US (2) US11220491B2 (https=)
EP (2) EP4545147A3 (https=)
JP (2) JP7454759B2 (https=)
KR (2) KR102866533B1 (https=)
CN (2) CN113015731B (https=)
AU (2) AU2019251579B2 (https=)
BR (1) BR112020020881A2 (https=)
CA (1) CA3096866A1 (https=)
DK (1) DK3774811T3 (https=)
ES (1) ES3015164T3 (https=)
FI (1) FI3774811T3 (https=)
HU (1) HUE070519T2 (https=)
IL (2) IL313054A (https=)
MX (1) MX2020010800A (https=)
PH (1) PH12020551677A1 (https=)
PL (1) PL3774811T3 (https=)
PT (1) PT3774811T (https=)
SG (1) SG11202010077TA (https=)
TW (2) TWI742359B (https=)
WO (1) WO2019200232A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102866533B1 (ko) 2018-04-12 2025-09-30 베르시컬러 테크놀로지스 엘엘씨 말라세지아-유래 화합물 및/또는 이의 화학적 유사체를 함유하는 광보호 조성물
JP2021527710A (ja) * 2018-06-15 2021-10-14 バーシカラー テクノロジーズ， エルエルシー マラセチア由来の化合物および／またはその化学的類縁体を含有する光保護組成物
JP2021535123A (ja) 2018-08-24 2021-12-16 マイケル アインジガー， ｍａｌａｓｓｅｚｉａ由来の化合物および／またはその化学アナログを含有する光保護性組成物
EA202092467A1 (ru) * 2018-10-08 2021-02-12 Майкл Айнцигер Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317925B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Bis-eterocicli ad attivita' antitumorale e chemosensibilizzante.
TW200716198A (en) * 2005-05-27 2007-05-01 Hayashibara Biochem Lab Agent for external application to the skin
EP2082736A1 (fr) 2008-01-23 2009-07-29 Jean Hilaire Saurat Composition pharmaceutique à usage topique
US20160030389A1 (en) 2013-03-13 2016-02-04 Alevere Medical Corporation Use of indole compounds for fat reduction and skin and soft tissue tightening
EP2933935A1 (en) 2014-04-14 2015-10-21 Alcatel Lucent A method of modulating light in a telecommunication network
US9969686B2 (en) 2014-08-05 2018-05-15 Wisconsin Alumni Research Foundation Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them
KR20160128764A (ko) 2015-04-29 2016-11-08 주식회사 엘지생활건강 피부 개선용 조성물
MA43730A (fr) * 2016-03-10 2018-11-28 Michael Einziger Malassezine et analogues correspondants en tant qu'agents d'éclaircissement de la peau
CN106916171B (zh) 2017-01-11 2019-02-26 华南师范大学 含有吲哚并[3，2-b]咔唑结构单元的压致变色材料及其应用
KR102866533B1 (ko) 2018-04-12 2025-09-30 베르시컬러 테크놀로지스 엘엘씨 말라세지아-유래 화합물 및/또는 이의 화학적 유사체를 함유하는 광보호 조성물
BR112020022708A2 (pt) 2018-05-07 2021-05-04 Michael EINZIGER composições fotoprotetoras contendo compostos derivados de malassezia e/ou análogos químicos dos mesmos
JP2021527710A (ja) * 2018-06-15 2021-10-14 バーシカラー テクノロジーズ， エルエルシー マラセチア由来の化合物および／またはその化学的類縁体を含有する光保護組成物
JP2021535123A (ja) * 2018-08-24 2021-12-16 マイケル アインジガー， ｍａｌａｓｓｅｚｉａ由来の化合物および／またはその化学アナログを含有する光保護性組成物
EA202092467A1 (ru) 2018-10-08 2021-02-12 Майкл Айнцигер Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги

Also Published As

Publication number Publication date
EP3774811A1 (en) 2021-02-17
IL277940B1 (en) 2024-07-01
US20190345140A1 (en) 2019-11-14
TW201946621A (zh) 2019-12-16
TW202432546A (zh) 2024-08-16
US12497385B2 (en) 2025-12-16
AU2019251579A1 (en) 2020-11-12
PT3774811T (pt) 2025-03-20
MX2020010800A (es) 2021-01-15
IL277940B2 (en) 2024-11-01
AU2024266874A1 (en) 2025-01-02
KR102866533B1 (ko) 2025-09-30
FI3774811T3 (fi) 2025-03-21
US11220491B2 (en) 2022-01-11
KR20250148678A (ko) 2025-10-14
EP4545147A2 (en) 2025-04-30
CN113015731A (zh) 2021-06-22
EP3774811B1 (en) 2024-12-18
IL313054A (en) 2024-07-01
IL277940A (en) 2020-11-30
TW202222307A (zh) 2022-06-16
SG11202010077TA (en) 2020-11-27
PL3774811T3 (pl) 2025-06-16
JP2021521195A (ja) 2021-08-26
KR20210075033A (ko) 2021-06-22
DK3774811T3 (da) 2025-03-17
CN113015731B (zh) 2024-09-10
JP7454759B2 (ja) 2024-03-25
AU2019251579B2 (en) 2024-08-29
JP2024091635A (ja) 2024-07-05
CA3096866A1 (en) 2019-10-17
JP7821824B2 (ja) 2026-02-27
WO2019200232A1 (en) 2019-10-17
EP4545147A3 (en) 2025-10-01
HUE070519T2 (hu) 2025-06-28
US20220106297A1 (en) 2022-04-07
TWI843963B (zh) 2024-06-01
ES3015164T3 (en) 2025-04-29
TWI742359B (zh) 2021-10-11
CN119350217A (zh) 2025-01-24
BR112020020881A2 (pt) 2021-04-20

Similar Documents

Publication Publication Date Title
PH12020551845A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PH12020551677A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PH12021550315A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PH12021550746A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PH12020552132A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PH12018501926A1 (en) Malassezin and analogs thereof as skin brightening agents
EA201591455A1 (ru) Производные бензимидазолона в качестве ингибиторов бромодомена
EA201890886A1 (ru) Композиция для отбеливания кожи
EA201690591A1 (ru) Композиция для осветления кожи
MX2014003449A (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.
WO2014090525A3 (de) Reduzierung des ammoniakgeruchs in mitteln zum oxidativen färben und/oder aufhellen von keratinischen fasern
MX2019014349A (es) Neurotoxina botulinica para el tratamiento de trastornos asociados con hiperactividad de los melanocitos y/o exceso de melanina.
MX358727B (es) Composicion cosmetica dermatologica que comprende una merocianina y una fase aceitosa que comprende al menos un compuesto amido especifico.
WO2014090526A3 (de) Wirkstoffkombination zur hautaufhellung i
BR112015017119A8 (pt) composição cosmética, processos cosméticos não terapêuticos para cuidado e/ou maquilagem de uma matéria queratínica, para limitar o escurecimento da pele e para evitar e/ou tratar os sinais de envelhecimento e usos de uma composição cosmética
EA201791493A1 (ru) Композиция для отбеливания кожи, содержащая ниацинамид и иломастат
MY189383A (en) Soyasaponin-containing composition for skin whitening
CL2022000208A1 (es) Péptidos reguladores de melanocito
MX2019002181A (es) Compuestos difluorados como agentes despigmentantes o aclarantes.
Napolitano et al. Human red hair pheomelanin is a potent pro-oxidant mediating Uv-independent mechanisms of oxidative stress in red hair phenotypes
MY169101A (en) Mixture for the inhibition of melanin biosynthesis
MX389900B (es) Difluoro compuestos de gema como agentes de despigmentación o de aclaramiento.
KR102750943B9 (ko) 데스메틸잔토휴몰을 유효성분으로 포함하는 피부 노화 또는 색소침착의 예방 또는 개선용 조성물
FR3060992B1 (fr) Composes depigmentants
Massey Prednisone/voriconazole